Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 3-Arm Randomized, Double-Masked, Placebo-Controlled, Phase 3 Study of NVK-002 in Children With Myopia

NCT03350620 is registered in ClinicalTrials.gov with Vyluma, Inc. as lead sponsor.

NCT NCT03350620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03350620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 3-Arm Randomized, Double-Masked, Placebo-Controlled, Phase 3 Study of NVK-002 in Children With Myopia
Lead sponsor
Vyluma, Inc.
Phase
Phase 3
Overall status
Completed
Start date
November 20, 2017
Completion date
October 19, 2023
Enrollment
670 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

myopia